Since these two fusion proteins have structurally similar domains, would MEF2C::SS18L1-positive B-ALL patients have similar clinical, pathological, or genetic features as MEF2D::SS18 positive patients? This evidence concerns the gene MEF2C and precursor B-cell acute lymphoblastic leukemia.